Country for PR: United States
Contributor: PR Newswire New York
Tuesday, May 22 2018 - 22:01
WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Japan
PRINCETON, New Jersey, May 22, 2018 /PRNewswire-AsiaNet/ --

--WCG expands global clinical research support presence 

WCG (TM) ( (WIRB-Copernicus Group (R)) Clinical 
Services Division, the world's leading provider of solutions that measurably 
improve the quality and efficiency of clinical research, today announced the 
opening of the company's new office in Tokyo, Japan. WCG's expanded presence in 
the Asia-Pacific region will strengthen its ability to support increasingly 
complex, global clinical trials, particularly in the critical areas of drug and 
diagnostic development for oncology and central nervous system (CNS) diseases. 


"WCG's Tokyo office will be home to our Clinical Services Division in Asia, as 
well as a center of excellence for our growing Patient Engagement Group," said 
Donald A. Deieso, PhD, chairman and CEO of WCG. "By expanding WCG's footprint 
abroad, we are helping to ensure that every trial— especially the most 
complicated and challenging ones—can benefit from our latest advances in trial 
optimization, signal detection and patient recruitment."

WCG maintains an active presence in 65 countries around the world, helping 
research sponsors, contract research organizations (CROs) and investigative 
sites to work together more effectively to conduct faster, safer, and more 
predictable clinical trials. 

In the past decade, Asia has become an increasingly attractive destination for 
clinical research, with a clinical trials infrastructure designed to foster 
speed, cost effectiveness and quality.  With a population of more than four 
billion people, Asia also provides research sponsors with access to a large 
number of patients for clinical trial recruitment. 

About WCG (WIRB-Copernicus Group)
WCG ( )(WIRB-Copernicus Group) 
( is the world's leading provider of solutions that 
measurably improve the quality and efficiency of clinical research. The 
industry's first clinical services organization (CSO), WCG enables 
biopharmaceutical companies, CROs, and institutions to accelerate the delivery 
of new treatments and therapies to patients, while maintaining the highest 
standards of human subject protections. For more information, please visit or follow us on Twitter @WCGClinical.

CONTACT: Media Contact: Lisa S. Osborne, Rana Healthcare Solutions, 
+1.206.992.5245, ; WCG Contact: Craig Sowell, Chief 
Marketing Officer, +1.609.945.0109,

SOURCE: WCG Clinical Services